Your browser doesn't support javascript.
ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh.
Halim, Mohammad Rabiul; Saha, Shuvajit; Haque, Injamam Ull; Jesmin, Sadia; Nishat, Rahatul Jannat; Islam, A S M D Ashraful; Roy, Seema; Haque, Miah Md Akiful; Islam, Md Motiul; Hamid, Tarikul; Ahmed, Kazi Nuruddin; Talukder, Md Azharul Islam; Ahmed, Arif; Hasan, Emran; Ananna, Nurjahan; Mohsin, Faroque Md; Hawlader, Mohammad Delwer Hossain.
  • Halim MR; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Saha S; Department of Maternal and Child Health, Projahnmo Research Foundation, Dhaka, Bangladesh.
  • Haque IU; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Jesmin S; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Nishat RJ; Department of Physiology, Sir Salimullah Medical College, Dhaka, Bangladesh.
  • Islam ASMDA; Department of Maternal and Child Health, Projahnmo Research Foundation, Dhaka, Bangladesh.
  • Roy S; Department of Medicine, Popular Medical College, Dhaka, Bangladesh.
  • Haque MMA; Department of Epidemiology, Public Health Professional Development Initiative (PPDI), Dhaka, Bangladesh.
  • Islam MM; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Hamid T; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Ahmed KN; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Talukder MAI; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Ahmed A; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Hasan E; Department of Maternal and Child Health, Projahnmo Research Foundation, Dhaka, Bangladesh.
  • Ananna N; Department of Critical Care Medicine, Central Police Hospital, Dhaka, Bangladesh.
  • Mohsin FM; Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare, Dhaka, Bangladesh.
  • Hawlader MDH; Department of Public Health, North South University, Dhaka, Bangladesh.
J Multidiscip Healthc ; 14: 2429-2436, 2021.
Article in English | MEDLINE | ID: covidwho-1403367
ABSTRACT

PURPOSE:

The world is heavily suffering from the COVID-19 pandemic for more than a year, with over 191 million confirmed cases and more than 4.1 million deaths to date. Previous studies have explored several risk factors for coronavirus disease 2019 (COVID-19), but there is still a lack of association with ABO blood type. This study aimed to find out the relationship between the ABO blood group and COVID-19 outcomes in Bangladesh. SUBJECTS AND

METHODS:

This retrospective cross-sectional study was conducted in the intensive care unit (ICU) of a tertiary-level COVID-dedicated hospital in Dhaka city, Bangladesh, between April 2020 and November 2020. Records from 771 critically ill patients were extracted who were confirmed for COVID-19 by reverse transcriptase-polymerase chain reaction (RT-PCR) assay, and blood grouping records were available in the health records.

RESULTS:

The blood groups were 37.35%, 17.38%, 26.46%, and 18.81% for A, B, AB, and O type, respectively. Clinical symptoms were significantly more common in patients with blood type A (p < 0.05). Patients with blood type A had higher WBC counts and peak serum ferritin levels and both were statistically significant (p < 0.001). Patients with blood type A had a greater need for supplemental oxygen, and they were more likely to die in comparison to the patients with other blood types (p < 0.05). In multivariable analysis, our primary outcome death was significantly associated with blood type A (AOR 3.49, 95% CI 1.57-7.73) while adjusting for age, male gender, and non-communicable diseases.

CONCLUSION:

Based on this study results, it can be concluded that the COVID-19 patients with blood type A have a higher chance of death and other complications. The authors recommend blood grouping before treating the COVID-19 patients, and healthcare workers should prioritize treating the patients based on that result.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Multidiscip Healthc Year: 2021 Document Type: Article Affiliation country: JMDH.S330958

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Multidiscip Healthc Year: 2021 Document Type: Article Affiliation country: JMDH.S330958